| Life Science Stars |
REGULATORYScott Bass, Washington, DC
Coleen Klasmeier, Washington, DC
William A Sarraille, Washington, DC
Jeffrey M Senger, Washington, DC
James C Stansel, Washington, DC
INTELLECTUAL PROPERTYThomas H Beck, New York
Jeffrey P Kushan, Washington DC
David T Pritikin, Chicago
M Patricia Thayer, San Francisco
Vernon M Winters, San Francisco
FINANCE & TRANSACTIONALDeborah A Marshall, Palo Alto
Pran Jha, Chicago
Jeffrey S Rothstein, Chicago
David J Zampa, Chicago
NON-IP LITIGATION AND ENFORCEMENTScott Bass, Washington, DC
Raymond A Bonner, Washington, DC
Michael W Davis, Chicago
Kimberly A Dunne, Los Angeles
Maja C Eaton, Chicago
Sara J Gourley, Chicago
Paul E Kalb, Washington, DC
Greer O Lautrup, Washington, DC
Debra E Pole, Los Angeles
Richard D Raskin, Chicago
John W Treece, Chicago
 |
"They provide an incredible range of legal expertise," one client emphatically declares about Sidley Austin, a global leader in the life sciences sector. "I turn to them without hesitation."
As a brand, Sidley Austin always rates as one of the top firms worldwide, and within the life sciences sector, the same rings true. The firm is an absolute powerhouse. "Every single partner, associate, and counsel in the group has been great," says one client about the firm. Sidley offers full-service capabilities with a deep knowledge of the industry and has built a tremendously talented multi-disciplinary group capable of handing the industry's most challenging subjects.
"Where they hit a home run, in my opinion, is that Sidley is far and away the best regulatory firm in the industry, especially on pricing," raves one client, highlighting Coleen Klasmeier's practice in particular. "The FDA thinks very highly of her. One of her documents [which she prepared on our behalf] was one of the most impressive I had ever seen."
Scott Bass, an industry leader for both FDA issues and government investigation work, has set a standard at the firm. "Scott imposes a consistency and quality that is important," says one client.
Strengthnening the marquee FDA practice is the firm's superior government investigation and enforcement group. Clients are regularly impressed by Ray Bonner, who handles safety, compliance and efficacy issues. "He is a former federal prosecutor and works with the district officers, the inspectors. He knows them all and has credibility with the district offices," explains one client. "We have had some really sensitive quality matters and I needed someone I really trusted. He has been fabulous." Bonner is joined by Kimberly Dunne, Greer Lautrup, Paul Kalb, and Richard Raskin, all of whom are industry leaders as well.
For litigation issues, both for intellectual property and product liability matters, Sidley scores high marks and outpaces most of the competition. For IP, Hatch-Waxman litigation is an area where the firm excels. It regularly handles work for industry powerhouses Eli Lilly, Schering-Plough, GlaxoSmithKline, Bristol-Myers Squibb, and Sanofi-Aventis.
On the product liability side, a foursome of Life Science Stars, including Michael Davis, Maja Eaton, Sara Gourley, and Debra Pole, regularly handle headline-grabbing cases. But just as important, the product team complements other practice areas by providing important advice on matters in order to avoid future litigation. Pre-litigation counseling stands as another example of how the practice group is fully integrated. By offering advice early on across a range of substantive areas, clients can prepare for potential claims down the line, preventing headaches.
Finally, clients are happy with how the firm staffs their matters. "I don't see a lot of associates on individual matters and their rates are competitive," says one client. "They don't bill you for every single thing, and they are efficient with running the cases and don't over staff."
Practice group breakdown of Life Science Stars
|
 |